Immunic Free Cash Flow Per Share from 2010 to 2024
IMUX Stock | USD 1.24 0.01 0.81% |
Free Cash Flow Per Share | First Reported 2010-12-31 | Previous Quarter (1.61) | Current Value (1.69) | Quarterly Volatility 564.02875244 |
Check Immunic financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Immunic main balance sheet or income statement drivers, such as Depreciation And Amortization of 105.5 K, Interest Expense of 730.2 K or Other Operating Expenses of 54.8 M, as well as many exotic indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0095 or PTB Ratio of 1.34. Immunic financial statements analysis is a perfect complement when working with Immunic Valuation or Volatility modules.
Immunic | Free Cash Flow Per Share |
Latest Immunic's Free Cash Flow Per Share Growth Pattern
Below is the plot of the Free Cash Flow Per Share of Immunic over the last few years. It is the amount of cash a company generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share. Immunic's Free Cash Flow Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Immunic's overall financial position and show how it may be relating to other accounts over time.
Free Cash Flow Per Share | 10 Years Trend |
|
Free Cash Flow Per Share |
Timeline |
Immunic Free Cash Flow Per Share Regression Statistics
Arithmetic Mean | (283.74) | |
Coefficient Of Variation | (198.78) | |
Mean Deviation | 371.79 | |
Median | (41.31) | |
Standard Deviation | 564.03 | |
Sample Variance | 318,128 | |
Range | 2.1K | |
R-Value | 0.55 | |
Mean Square Error | 237,333 | |
R-Squared | 0.31 | |
Significance | 0.03 | |
Slope | 69.91 | |
Total Sum of Squares | 4.5M |
Immunic Free Cash Flow Per Share History
About Immunic Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Immunic income statement, its balance sheet, and the statement of cash flows. Immunic investors use historical funamental indicators, such as Immunic's Free Cash Flow Per Share, to determine how well the company is positioned to perform in the future. Although Immunic investors may use each financial statement separately, they are all related. The changes in Immunic's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Immunic's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Immunic Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Immunic. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Free Cash Flow Per Share | (1.61) | (1.69) |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Immunic in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Immunic's short interest history, or implied volatility extrapolated from Immunic options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Immunic Correlation against competitors. For more information on how to buy Immunic Stock please use our How to Invest in Immunic guide.You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Complementary Tools for Immunic Stock analysis
When running Immunic's price analysis, check to measure Immunic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunic is operating at the current time. Most of Immunic's value examination focuses on studying past and present price action to predict the probability of Immunic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunic's price. Additionally, you may evaluate how the addition of Immunic to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |
Is Immunic's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunic. If investors know Immunic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.11) | Return On Assets (0.68) | Return On Equity (1.31) |
The market value of Immunic is measured differently than its book value, which is the value of Immunic that is recorded on the company's balance sheet. Investors also form their own opinion of Immunic's value that differs from its market value or its book value, called intrinsic value, which is Immunic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunic's market value can be influenced by many factors that don't directly affect Immunic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immunic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.